Kenneth Silverman, Ph.D.

Professor of Psychiatry and Behavioral Sciences
Director, Center for Learning and Health

Personal Data:

Business Address

Center for Learning and Health
Mason F. Lord Building, 142 West
5200 Eastern Avenue
Baltimore, MD 21224
Phone: (410) 550-2694
Fax: (410) 550-7495
e-mail: ksilverm@jhmi.edu

Education and Training:

B.A., 1975, University of Florida, Psychology (Honors)
M.A., 1982, University of Kansas, Human Development
Ph.D., 1984, University of Kansas, Developmental and Child Psychology
Postdoctoral Fellow, 1984-1985, University of Kansas, Child Language Research
Postdoctoral Fellow, 1989-1991, Johns Hopkins University School of Medicine, Behavioral Pharmacology

Professional Experience:

Psychology Research Trainee, Kansas Neurological Institute, Topeka, KS, 1979-1984
Research Associate, Bureau of Child Research, University of Kansas, Lawrence, KS, 1985
Research, Development, and Production, Behavior Tech, Inc., Dallas, TX, 1985-1988
Instructor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 1991-1993
Staff Fellow, Clinical Trials Section, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 1992-1993
Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 1993-1998
Founder and Director, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 1996-present
Associate Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 1998-present

Chairman and President, Center for Learning and Health Corporation and Johns Hopkins Data Services, a Johns Hopkins University affiliated not-for-profit entity, 2000-present
Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 2004-present

RESEARCH ACTIVITIES

Selected Publications:

Peer-Reviewed Scientific Articles
  1. Lyons CA, Silverman K, Cheney CD. Dimensional stimulus control of key pecking maintained by stimulus-reinforcer dependencies. Behaviour Analysis Letters. 1983; 3: 65-76.

  2. Silverman K, Watanabe K, Marshall AM, Baer DM. Reducing self-injury and corresponding self-restraint through the strategic use of protective clothing. Journal of Applied Behavior Analysis. 1984; 17: 545-552.

  3. Silverman K, Anderson SR, Marshall AM, Baer DM. Establishing and generalizing audience control of new language repertoires. Analysis and Intervention in Developmental Disabilities. 1986; 6: 21-40.

  4. Silverman K, Griffiths RR. Low-dose caffeine discrimination and self-reported mood effects in normal humans. Journal of the Experimental Analysis of Behavior. 1992; 57: 91-107.

  5. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. The New England Journal of Medicine. 1992; 327: 1109-1114.

  6. Silverman K, Evans SM, Strain EC, Griffiths RR. Syndrome de sevrage après arrêt en double-aveugle de la consommation de caféine. Le Journal International de Medécine. 1992; 252: 26-32. (Reprinted from NEJM. 1992; 327: 1109-1114).

  7. Griffiths RR, Troisi JR, Silverman K, Mumford GK. The multiple-choice procedure: An efficient method for investigating drug reinforcement. Behavioural Pharmacology. 1993; 4: 3-13.

  8. Silverman K, Kirby KC, Griffiths RR. Modulation of drug reinforcement by the behavioral requirements following drug ingestion. Psychopharmacology. 1994; 114: 243-247.

  9. Silverman K, Mumford GK, Griffiths RR. Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology. 1994; 114: 424-432.

  10. Silverman K, Mumford GK, Griffiths RR. A procedure for studying the within-session onset of human drug discrimination. Journal of the Experimental Analysis of Behavior. 1994; 61: 181-189.

  11. Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR. Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology. 1994; 115: 1-8.

  12. Strain EC, Mumford GK, Silverman K, Griffiths RR. Caffeine dependence syndrome: Evidence from case histories and experimental evaluations. Journal of the American Medical Association. 1994; 272: 1043-1048.

  13. Strain EC, Mumford GK, Silverman K, Griffiths RR. Caffeine dependence syndrome. Journal of the American Medical Association. 1995; 273: 1418-1419.

  14. Silverman K, Chutuape M, Svikis DS, Bigelow GE, Stitzer ML. Incongruity between occupational interests and academic skills in drug abusing women. Drug and Alcohol Dependence. 1995; 40: 115-123.

  15. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Archives of General Psychiatry. 1996; 53: 409-415.

  16. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, Umbricht-Schneiter A, Schuster CR, Preston KL. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug and Alcohol Dependence. 1996; 41: 157-165.

  17. Silverman K, Chutuape M, Bigelow GE, Stitzer ML. Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program. Drug and Alcohol Dependence. 1996; 41: 197-207.

  18. Mumford GK, Benowitz NL, Evans SM, Kaminski BJ, Preston KL, Sannerud, CA, Silverman K, Griffiths RR. Absorption rate of methylxanthines following capsules, cola, and chocolate. European Journal of Clinical Pharmacology. 1996; 51: 319-325.

  19. Mumford GK, Silverman K, Griffiths RR. Reinforcing, subjective and performance effects of lorazepam and diphenhydramine in humans. Experimental and Clinical Psychopharmacology. 1996; 4: 421-430.

  20. Preston KL, Silverman K, Schuster CR, Cone EJ. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction. 1997; 92: 717-727.

  21. Bigelow GE, Brooner RK, Silverman K. Competing motivations: drug reinforcement versus non-drug reinforcement. Journal of Psychopharmacology. 1997; 12: 8-14.

  22. Chutuape M, Silverman K, Stitzer ML. Survey assessment of methadone treatment services as reinforcers. The American Journal of Drug and Alcohol Abuse. 1998; 24: 1-16.

  23. Preston KL, Silverman K, Higgins ST, Brooner RK, Montoya I, Schuster CR, Cone EJ. Cocaine use early in treatment predicts outcome in a behavioral treatment program. Journal of Consulting and Clinical Psychology. 1998; 66: 691-696.

  24. Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL. Broad beneficial effects of reinforcement for cocaine abstinence in methadone patients. Journal of Consulting and Clinical Psychology. 1998; 66: 811-824.

  25. Chutuape MA, Silverman K, Stitzer ML. Use of methadone take-home contingencies with persistent opiate and cocaine abusers. Journal of Substance Abuse Treatment. 1999; 16: 23-30.

  26. Preston KL, Silverman K, Unbricht A, DeJesus A, Montoya ID, Schuster CR. Improvement in naltrexone treatment compliance with contingency management. Drug and Alcohol Dependence. 1999; 54: 127-135.

  27. Chutuape M, Silverman K, Stitzer ML. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients. Drug and Alcohol Dependence. 1999; 54: 69-81.

  28. Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology. 1999; 146: 128-138.

  29. Robles E, Silverman K, Preston KL, Cone EJ, Katz E, Bigelow GE, Stitzer ML. The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug and Alcohol Dependence. 2000; 58: 205-212.

  30. Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: 6-month abstinence outcomes. Experimental and Clinical Psychopharmacology. 2001; 9: 14-23.

  31. Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. Towards application of the therapeutic workplace: Reply to Higgins, Marlatt, McLellan, and Petry. Experimental and Clinical Psychopharmacology. 2001; 9: 35-39.

  32. Jones HE, Haug N, Silverman K, Stitzer ML, Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug and Alcohol Dependence. 2001; 61: 297-306.

  33. Chutuape MA, Silverman K, Stitzer ML. Effects of urine testing frequency on outcome in a methadone take-home contingency program. Drug and Alcohol Dependence. 2001; 62: 69-76.

  34. Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Experimental and Clinical Psychopharmacology. 2001; 9: 317-325.

  35. Robles E, Stitzer ML, Strain EC, Bigelow GE, Silverman K. Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug and Alcohol Dependence. 2002; 65: 179-189.

  36. Katz EC, Robles-Sotelo E, Correia CJ, Silverman K, Stitzer ML, Bigelow GE. The Brief Abstinence Test: Effects of Continued Incentive Availability on Cocaine Abstinence. Experimental and Clinical Psychopharmacology. 2002; 10: 10—17.

  37. Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: 3-year abstinence outcomes. Experimental and Clinical Psychopharmacology. 2002; 10: 228-240. (Special Issue on Substance Abuse Treatment).

  38. Wong CJ, Sheppard JM, Dallery J, Bedient G, Robles E, Svikis D, Silverman K. Effects of reinforcer magnitude on data entry productivity in chronically unemployed drug abusers participating in a Therapeutic Workplace. Experimental and Clinical Psychopharmacology. 2003; 11: 46-55.

  39. Correia CJ, Dallery J, Katz EC, Silverman K, Bigelow G, Stitzer ML. Single-versus dual-drug target: effects in a brief abstinence incentive procedure. Experimental and Clinical Psychopharmacology. 2003; 11: 302-308.

  40. Wong CJ, Dillon EM, Sylvest CE, Silverman K. Contingency management of reliable attendance of chronically unemployed substance abusers in a therapeutic workplace. Experimental and Clinical Psychopharmacology. 2004; 12: 39-46.

  41. Silverman K, Wong CJ, Grabinski MJ, Hampton J, Sylvest CE, Dillon EM, Wentland RD. (in press). A web-based therapeutic workplace training program and business for the treatment of drug addiction and chronic unemployment. Behavior Modification (Special Issue on HIV Prevention).

  42. Dillon EM, Wong CJ, Sylvest CE, Crone-Todd DE, Silverman K. (in press). Computer-based typing and keypad skills training outcomes of unemployed injection drug users in a therapeutic workplace. Substance Use and Misuse.

  43. Wong CJ, Dillon EM, Sylvest CE, Silverman K. (in press). Contingency management of reliable attendance of chronically unemployed substance abusers in a therapeutic workplace. Experimental and Clinical Psychopharmacology.

  44. Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML. (in press). A randomized trial of long-term reinforcement of cocaine abstinence in methadone maintained injection drug users. Journal of Consulting and Clinical Psychology.

  45. Wong CJ, Dillon EM, Sylvest CE Silverman K. (in press). Evaluation of a modified contingency management intervention for consistent attendance in therapeutic workplace participants. Drug and Alcohol Dependence.

  46. Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML. (in press). A randomized trial of long-term reinforcement of cocaine abstinence in methadone maintained injection drug users. Journal of Consulting and Clinical Psychology.

Book Chapters and Monographs
  1. Schuster CR, Silverman K. (1994). Advancing the application of behavioral treatment approaches for drug dependence. In LS Onken, JD Blaine, JJ Boren (Eds.), Behavioral Treatments for Drug Abuse and Dependence (pp. 5-17). NIDA Research Monograph No. 137, NIH Publication No. 93-3684. Washington, DC: Government Printing Office.

  2. Silverman K, Griffiths RR. (1995). Caffeine. In JH Jaffe (Ed.), Encyclopedia of Drugs and Alcohol, Volume 1 (pp. 183-189). New York: Simon & Schuster Macmillan.

  3. Silverman K, Griffiths RR. (1995). Coffee. In JH Jaffe (Ed.), Encyclopedia of Drugs and Alcohol, Volume 1 (pp. 250-251). New York: Simon & Schuster Macmillan.

  4. Silverman K, Griffiths RR. (1995). Tea. In JH Jaffe (Ed.), Encyclopedia of Drugs and Alcohol, Volume 3 (pp. 1018-1019). New York: Simon & Schuster Macmillan.

  5. Silverman K. (1997). Caffeine as a model drug of abuse for the development of sensitive behavioral measures. In DM Baer, EM Pinkston (Eds.), Environment and Behavior (pp. 194-202). Boulder, Colorado: Westview Press.

  6. Preston KL, Silverman K, Schuster CR, Cone EJ. (1997). Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. In L Harrison, A Hughes (Eds.), The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates (pp. 130-145). NIDA Research Monograph No. 167, Washington, DC: Government Printing Office.

  7. Preston KL, Silverman K, Schuster CR, Cone EJ. (1997). Use of quantitative urinalysis in monitoring cocaine use. In P Bridge, N Chiang, B Tai (Eds.), Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials (pp. 253-264). NIDA Research Monograph No.175, Washington, DC: Government Printing Office.

  8. Silverman K, Robles E. (1998). Employment as a drug abuse treatment intervention: A behavioral economic analysis. National Bureau of Economic Research Working Paper No.6402. Cambridge, MA: National Bureau of Economic Research, Inc.

  9. Silverman K, Bigelow GE, Stitzer ML. (1998). Treatment of cocaine abuse in methadone patients. In ST Higgins, JL Katz (Eds.), Cocaine Abuse: Behavior, Pharmacology, and Clinical Applications (pp. 363-388). San Diego, CA: Academic Press, Inc.

  10. Silverman K, Robles E. (1999). Employment as a drug abuse treatment intervention: A behavioral economic analysis. In FJ Chaloupka, WK Bickel, M Grossman, H Saffer (Eds.), The Economic Analysis of Substance Use and Abuse: An Integration of Econometric and Behavioral Economic Research (pp. 279-299). Chicago, IL: University of Chicago Press.

  11. Silverman K, Preston KL, Stitzer ML, Schuster CR. (1999). Efficacy and versatility of voucher-based reinforcement in drug abuse treatment. In ST Higgins, K Silverman (Eds.), Motivating Behavior Change Among Illicit-Drug Abusers: Research on Contingency Management Interventions (pp. 163-181). Washington, DC: American Psychological Association Books.

  12. Preston KL, Silverman K, Cone EJ. (1999). Monitoring cocaine use during contingency management interventions. In ST Higgins, K Silverman (Eds.), Motivating Behavior Change Among Illicit-Drug Abusers: Research on Contingency Management Interventions (pp. 283-308). Washington, DC: American Psychological Association Books.

  13. Bigelow GE, Silverman K. (1999). Theoretical and empirical foundations of contingency management treatments for drug abuse. In ST Higgins, K Silverman (Eds.), Motivating Behavior Change Among Illicit-Drug Abusers: Research on Contingency Management Interventions (pp. 15-31). Washington, DC: American Psychological Association Books.

  14. Robles E, Silverman K, Stitzer ML. (1999). Contingency management therapies. In EC Strain, ML Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 196-222). Baltimore, MD: Johns Hopkins University Press.

  15. Silverman K, Wong CJ, Svikis D, Stitzer ML, Bigelow GE. (2001). The Therapeutic Workplace: A Promising Treatment for Heroin and Cocaine Addiction Among the Chronically Unemployed. Proceedings of the 2001 ONDCP International Technology Symposium. Washington, DC.

  16. Higgins ST, Silverman K, Heil SH. (2003). Behavioral interventions for problem drinking: Community reinforcement and contingency management. In B Johnson, P Ruiz, MJ Galanter (Eds.), Handbook of Clinical Alcoholism Treatment (pp. 111-118). Baltimore, MD: Lippincott, Williams & Wilkins.

  17. Silverman K, Higgins ST, Bickel WK. (2003). The Therapeutic Workplace: Applied Behavior Analysis in the Treatment of Drug Addiction. In KS Budd, T Stokes (Eds.), A Small Matter of Proof: The Legacy of Donald M. Baer (pp. 195-210). Reno, NV: Context Press.

Book

Higgins ST, Silverman K. (Eds.). (1999). Motivating Behavior Change Among Illicit-Drug Abusers: Research on Contingency Management Interventions. Washington, DC: American Psychological Association Books.

Invention:

Therapeutic Workplace Software Application Program, 2001 (JHU Ref.: 4188)


Selected Grants Extramural Sponsorship:

Title: "A Therapeutic Workplace to Prevent HIV Transmission"

Dates: 06/15/1999-05/31/2004

Sponsor: National Institute on Drug Abuse, NIH

Identification Number: R01 DA12564

Role: Principal Investigator

Principal Investigator: Silverman K


Title: "A Therapeutic Workplace for Homeless Alcoholics"

Dates: 04/01/2000-03/31/2005

Sponsor: National Institute on Alcohol Abuse and Alcoholism, NIH

Identification Number: R01 AA12154

Role: Principal Investigator

Principal Investigator: Silverman K


Title: "A Reinforcement-Based Therapeutic Workplace"

Dates: 9/30/2002-06/30/2007

Sponsor: National Institute on Drug Abuse, NIH

Identification Number: R01 DA13107

Role: Principal Investigator

Principal Investigator: Silverman K


Title: "A Reinforcement-Based Therapeutic Workplace"

Dates: 09/30/1999-08/31/2002

Sponsor: National Institute on Drug Abuse, NIH

Identification Number: R01 DA13107

Role: Principal Investigator

Principal Investigator: Silverman K


Title: "A Therapeutic Workplace Data Entry Business"

Dates: 05/15/1999-03/31/2001

Sponsor: Abell Foundation

Principal Investigator: Silverman K


Title: "A Therapeutic Workplace for Drug Abusers"

Dates: 04/01/1996-03/31/1999

Sponsor: National Institute on Drug Abuse, NIH

Role: Principal Investigator

Principal Investigator: Silverman K


Center Component: "Voucher-Based Reinforcement Therapies in Methadone Patients"

Dates: 09/20/1994-08/31/1999

Sponsor: National Institute on Drug Abuse, NIH

Identification Number: P50 DA 09258

Role: Principal Investigator, Center Component

Center Principal Investigator: Stitzer ML

 CLINICAL-ADMINISTRATIVE ACTIVITIES

Founder and Director, Center for Learning and Health (1996-present)

Mission. The Center for Learning and Health is a treatment-research unit focused on developing and evaluating novel operant treatments to address the interrelated problems of poverty and substance abusedrug addiction.

Main Programs

 Therapeutic Workplace Training Program. (6/1996-present; 35 treatment slots) A novel employment-based drug abuse treatment program that provides basic skills education, job skills training, social skills development, and abstinence contingent salary to chronically unemployed substance abusers.

Therapeutic Workplace Business: Johns Hopkins Data Services. (4/2000-present; 15 treatment slots). A data entry business that employs successful participants from the Therapeutic Workplace Training Program as data entry operators. This business maintains long-term salary-based abstinence reinforcement, employment, and tailored contingencies to maintain high quality job performance. The business provides double data entry services to researchers at Johns Hopkins University and surrounding community. (Website: http://www.hopkinsmedicine.org/hds)

E-mail contact: ksilverm@jhmi.edu

Updated: 5/6/2004
http://bpru.med.jhu.edu/bio/silverman.html